Calendar OliX Pharmaceuticals, Inc

Equities

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
15,200 ^KRW	+3.33%		-0.65%	+4.25%

Mar. 22	OliX Pharmaceuticals, Inc announced that it has received KRW 14.7 billion in funding from a group of investors	CI
Mar. 20	OliX Pharmaceuticals, Inc announced that it expects to receive KRW 14.7 billion in funding from a group of investors	CI

cab7d2bf546.qvXWfr45jAR9ExdTONGrnGHwdqfzQ8T1I3bHIx09JvM.zbifJ81o5khIY1IrCZ7lqi--GcOgKJSDFj71Ekp1aZDpmYAf9wjYSRd5Jw~45d128c55ce8be9ecb74e1c64dffa1b0

2024-08-08	Q2 2024 Earnings Release (Projected)
2025-03-13	Q4 2024 Earnings Release (Projected)
2025-05-08	Q1 2025 Earnings Release (Projected)

2024-05-09	Q1 2024 Earnings Release (Projected)
2024-03-27 08:30 pm	Annual General Meeting
2024-03-17	Q4 2023 Earnings Release
2024-01-30	Non-Deal Roadshow
2023-08-10	Q2 2023 Earnings Release
2023-07-24	Roadshow - Day - 2
2023-07-23	Roadshow - Day - 1
2023-05-11	Q1 2023 Earnings Release
2023-03-16	Q4 2022 Earnings Release
2022-11-10	Q3 2022 Earnings Release
2022-08-11	Interim 2022 Earnings Release
2022-06-12	BIO International Convention
2022-05-15	Q1 2022 Earnings Release
2022-03-27	BIO Europe Spring Conference
2022-02-10 04:10 am	RNA Therapeutics Conference
2021-10-24	BIO Europe Digital Conference
2021-09-25	Oligonucleotide Therapeutics Society Virtual Conference
2021-08-16	Interim 2021 Earnings Release
2021-08-03	Korean Academy of Science and Technology International Symposium
2021-06-16 04:00 pm	RNAi-Based Therapeutics Summit

Fiscal Period	December	2019	2020
Net sales Billions KRW	Released Forecast Spread	1,13 0,40 182.58%	2,47 0,40 518.57%
EBITDA Billions KRW	Released Forecast Spread	-14,3 -9,30 -54.21%	-15,1 -10,1 -49.51%
EBIT Billions KRW	Released Forecast Spread	-15,1 -10,2 -48.2%	-16,2 -11,0 -47.65%
Earnings before Tax (EBT) Billions KRW	Released Forecast Spread	-14,2 -9,60 -48.37%	-20,5 -10,5 -95.34%
Net income Billions KRW	Released Forecast Spread	-14,4 -9,60 -49.51%	-19,4 -10,4 -86.73%
EPS KRW	Released Forecast Spread	-1 102 -737 -49.63%	-1 474 -794 -85.76%
Announcement Date		28/01/20	26/01/21

2024-05-15	BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 09:00 am	ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-17 07:00 am	AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-07-23	VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24	BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am	ARGENX SE: Q2 2024 Earnings Release
2024-07-29	RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29	NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29	CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30	CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)

Today	CELCUITY INC.: Q1 2024 Earnings Release
2024-05-13	IMMATICS N.V.: Q1 2024 Earnings Release (Projected)
2024-05-13	ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-13	PEPTIDREAM INC.: Q1 2024 Earnings Release
2024-05-13	NYKODE THERAPEUTICS: Q1 2024 Earnings Release
2024-05-13	ABL BIO INC.: Q1 2024 Earnings Release (Projected)
2024-05-13	LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release (Projected)
2024-05-13 04:01 pm	ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-12	PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release
2024-05-12	INNOCARE PHARMA LIMITED: Q1 2024 Earnings Release